Ras effectors

Current Opinion in Cell Biology

Volumn 8, Issue 2, 1996, Pages 197-204

  Marshall, Christopher J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MUTANT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE; RAS PROTEIN; RHO FACTOR;

BINDING AFFINITY; CARCINOGENESIS; CELL TRANSFORMATION; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029944442     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80066-4     Document Type: Article

References (64)

1. Mulcahy LS, Smith MR, Stacey DW: Requirement for ras protooncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985, 313:241-243.
2. Woodrow MA, Rayter S, Downward J, Cantrell DA: p21(ras) function is important for T-cell antigen receptor and protein kinase-C regulation of nuclear factor of activated T-cells. J Immunol 1993, 150:3853-3861.
3. Van Corven EJ, Hordijk PL, Medema RH, Bos JL, Moolenaar WH: Pertussis toxin-sensitive activation of p21 ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 1993, 90:1257-1261.
4. Marshall CJ: Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
5. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994, 77:841-852. The first evidence that the activation of the ERK MAPK pathway is required for Ras to transform cells. Constitutively active Mek is shown to transform NIH3T3 cells and to differentiate PC12 cells.
6. Pai EF, Kabsch W, Krengel U, Holmes KC, John J, Wittinghofer A: Structure of the guanine nucleotide domain of the Ha-ras oncogene product p21 in the triphosphate conformation. Nature 1989, 341:209-214.
7. Milbum MV, Tong L, De Vos AM, Brüner A, Yamaizumi Z, Nishimura S, Kim S-H: Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science 1990, 247:939-945.
8. Pai EF, Krengel U, Petsko GA, Goody RS, Kabsch W, Wittinghofer A: Refined crystal structure of the triphosphate conformation of H-ras at 1.35Å resolution: implications for the mechanism of GTP hydrolysis. EMBO J 1990, 9:2351-2359.
9. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A: The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 1995, 375:554-560. The first crystal structure which shows how a small GTPase of the Ras subfamily of GTPases complexes to an effector.
10. ••]), may be involved in binding other effectors such as P13K.
11. Brtva TR, Drugan JK, Ghosh S, Terrell RS, Campbell-Burk S, Bell RM, Der CJ: Two distinct Raf domains mediate interaction with Ras. J Biol Chem 1995, 270:9809-9812. Presents evidence that the cysteine-rich domain of Raf-1 (amino acids 139-184), in addition to the RBD (amino acids 51-131), may be involved in Ras binding.
12. Trahey M, Wong G, Halenbeck R, Rubinfeld B, Martin GA, Ladner M, Long CM, Crosier WJ, Watt K, Kolhs K, McCormick F: Molecular cloning of two types of GAP complementary DNA from human placenta. Science 1988, 242:1697-1700.
13. Martin GA, Viskochil D, Ballag G, McCabe PC, Crosier W, Haubruck H, Conroy L, Clark R, O'Connel P, Cawthorn RM et al.:The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990, 63:843-849.
14. Martin GA, Yatani A, Clark R, Conroy L, Polakis P, Brown AM, McCormick F: GAP domains responsible for Ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science 1992, 255:192-194.
15. Medema RH, De Laat WI, Martin GA, McCormick F, Bos JL: GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol 1992, 12:3425-3430.
16. Duchesne M, Schweighoffer F, Parker F, Clerc F, Frobert Y, Thang MN, Tocque B: Identification of the SH3 domain of GAP as an essential sequence for Ras-GAP-mediated signaling. Science 1993, 259:525-528.
17. Toda T, Uro I, Ishikawa T, Powers S, Kataoka T, Broek D, Cameron S, Broach J, Matsumoto K, Wigler M: In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell 1985, 40:27-36.
18. Wang Y, Xu H, Riggs M, Rogers L, Wigler M: byr2, a Schizosaccharomyces pombe gene encoding a protein kinase capable of partial suppression of the ras1 mutant phenotype. Mol Cell Biol 1991, 11:3554-3563.
19. Chang EC, Barr M, Wang Y, Jung V, Xu H-P, Wigler MH: Cooperative interaction of S. pombe proteins required for mating and morphogenesis. Cell 1994, 79:131-141. This paper provides evidence from genetics and protein-protein interactions for the interplay between Ras and Rho-like GTPase pathways.
20. Dickson B, Hafen E: Genetics of signal transduction in invertebrates. Curr Opin Genet Dev 1994, 4:64-70.
21. Vojtek AB, Hollenberg SM, Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993, 74:205-214.
22. Aelst LV, Barr M, Marcus S, Polverino A, Wigler M: Complex formation between RAS and RAF and other protein kinases. Proc Natl Acad Sci USA 1993, 90:6213-6217.
23. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993, 364:308-313.
24. Warne PH, Viciana PR, Downward J: Direct Interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 1993, 364:352-355.
25. ••].
26. ••).
27. ••], provides evidence that exchange factors for p27Ral may be effectors of Ras, and provides evidence for linkage between the GTPases Ras and Ral.
28. Van Aelst L, White M, Wigler MH: Ras partners. Cold Spring Harb Symp Quant Biol 1994, 59:181-186.
29. Jiang H, Luo J-Q, Urano T, Frankel P, Lu Z, Foster DA, Feig LA: Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995, 378:409-412. Phospholipase D (PLD), which hydrolyzes phospholipids to generate phosphatidic acid, is shown to be associated with p27Ral, and dominant-negative mutants of Ral block PLD activation in Ras-transformed cells. These results argue that Ral is a regulator of PLD, and that Ras could activate PLD via activation of Ral-GDS.
30. Wolfman A, Macara IG: Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 1987, 325:359-361.
31. Han J, Colicelli J: A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol Cell Biol 1995, 15:1318-1323.
32. Rodriguez-Viciana P, Wame PH, Dhand R, Vanhaesebroeck B, Gout I, Fry M, Waterfield MD, Downward J: Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994, 370:527-532. Direct biochemical evidence for the interaction between P13K and Ras, suggesting that P13K is an effector of Ras.
33. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, Moscat J: Evidence for the in vitro and in vivo interaction of ras with protein kinase C ζ. Biol Chem 1994, 269:31706-31710. Protein kinase C-ζ is shown to interact with p21Ras-GTP in vitro.
34. Russell M, Lange CC, Johnson GL: Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 1995, 270:11757-11760. MEKK-1, a MAPKKK in the Jnk MAPK pathway, is shown to bind p21Ras-GTP in vitro.
35. Cox AD, Brtva TR, Lowe DG, Der CJ: R-Ras induces malignant, but not morphologic transformation of NIH3T3 cells. Oncogene 1994, 9:3281-3288. This paper shows for the first time that R-Ras can be an oncoprotein, but that there are differences in the mechanisms of transformation by R-Ras and by Ras.
36. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M: A ras-related gene with transformation suppressor activity. Cell 1989, 56:77-84.
37. Herrmann C, Martin GA, Wittinghofer A: Quantitative analysis of the complex between p21 ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 1995, 270:2901-2905. A quantitative assay, which exploits the fact that effector binding inhibits the dissociation of GTP from p21Ras, is used to measure the dissociation constant of the Ras-Raf interaction. H-Ras, K-Ras and N-Ras are compared with each other and with some oncogenic mutants of Ras.
38. Wittinghofer A, Herrmann C: Ras-effector interactions, the problem of specificity. FEBS Lett 1995, 369:52-56. A careful consideration of the interactions between GTPases and their putative effectors.
39. Hallberg B, Rayter SI, Downward J: Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J Biol Chem 1994, 269:3913-3916.
40. Traverse S, Cohen P, Paterson H, Marshall CJ, Rapp U, Grand RJA: Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene 1993, 8:3175-3181.
41. Wartmann M, Davis RJ: The native structure of the activated raf protein kinase is a membrane-bound multi-subunit complex. J Biol Chem 1994, 269:6695-6701. This paper demonstrates that p74Raf-1 is associated with cellular membranes following growth factor stimulation.
42. Smith MR, DeGubicus SJ, Stacey DW: Requirement for c-ras proteins during viral oncogene transformation. Nature 1986, 320:540-543.
43. ••] because it argues that P13K is an activator of Ras, not a downstream effector. At present there are no data to reconcile these disparate observations.
44. Stanton VP, Cooper GM: Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences. Mol Cell Biol 1987, 7:1171-1179.
45. Yamamori B, Kuroda S, Shimizu K, Fukui K, Ohtsuka T, Takai Y: Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J Biol Chem 1995, 270:11723-11726. The best evidence published so far that p21Ras-GTP directly activates a Raf family member. Note that this paper demonstrates that p21 Ras must be prenylated for activation of a Raf family member to take place (see [47]).
46. Manser E, Leung T, Salihuddin H, Zhaos ZS, Lim L: A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994, 367:40-46.
47. Itoh T, Kaibuchi K, Masuda T, Yamamoto T, Matsuura Y, Maeda A, Shimizu K, Takai Y: The post-translational processing of ras p21 is critical for its stimulation of mitogen-activated protein kinase. J Biol Chem 1993, 268:3025-3028.
48. Kuroda Y, Suzuki N, Kataoka T: The effect of post-translational modifications on the interaction of Ras2 with adenylyl cyclase. Science 1993, 259:683-689.
49. ••].
50. •]).
51. Marais R, Light Y, Paterson HF, Marshall CJ: Ras recruits RaF-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 1995, 14:3136-3145. The interaction between Ras and Raf-1 is shown to bring Raf-1 to the plasma membrane for tyrosine phosphorylation, arguing that one mechanism of Raf-1 activation is Ras-dependent tyrosine phosphorylation. This paper also shows that Raf-1 is activated by mechanisms other than tyrosine phosphorylation.
52. White MA, Nicolette C, Minden A, Polverino A, Van Aelst A, Karin M, Wigler MH: Multiple Ras functions can contribute to mammalian cell transformation. Cell 1995, 80:533-541. Different effector mutants of Ras are used to produce results that argue that there is cooperation between multiple Ras-activated pathways in transformation
53. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995, 92:7686-7689. A synthetic inhibitor is shown to block MEK activity and to reverse transformation of Ras-transformed cells.
54. Lloyd AC, Paterson HF, Morris JDH, Hall A, Marshall CJ: p21H-ras induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C. EMBO J 1989, 8:1099-1104.
55. Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 1994, 266:285-288.
56. ••].
57. ••] demonstrated for the first time that transformation by Ras requires the activation of Rho family GTPases.
58. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A: The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
59. ••].
60. ••] suggest a mechanism by which Ras-dependent activation of P13K could lead to the activation of Rac.
61. Satoh T, Endo M, Nakafuku M, Nakamura S, Kaziro Y: Platelet-derived growth factor stimulates formation of active p21 ras-GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 1990, 87:5993-5997.
62. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal-transductlon pathways from Interleukin-2, interleukin-3 and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 1991, 88:3314-3318.
63. Vogel US, Dixon RA, Schaber MD, Diehl RE, Marshall MS, Scolnick EM, Sigal IS, Gibbs JB: Cloning of bovine gap and its interaction with oncogenic ras p21. Nature 1988, 335:90-93.
64. Bos JL: The ras gene family and human carcinogenesis. Mutat Res 1988, 195:255-271.